Paratek Pharmaceuticals Inc (PRTK) - Financial and Strategic SWOT Analysis Review

  • ID: 4281608
  • SWOT Analysis
  • 44 pages
  • GlobalData
  • Paratek Pharmaceuticals
1 of 5

FEATURED COMPANIES

  • Argos Therapeutics Inc
  • Chimerix Inc
  • Titan Pharmaceuticals Inc
  • MORE
Paratek Pharmaceuticals Inc (PRTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Paratek Pharmaceuticals Inc (Paratek) is a biopharmaceutical company that develops and commercializes therapies based on tetracycline chemistry. The company’s lead product candidate is an antibiotic called omadacycline, an aminomethylcycline which acts against gram-negative, gram-positive, and atypical bacteria. It is investigating omadacycline in phase 3 for the treatment of infections resistant to antibiotics: acute bacterial skin and skin structure infections (ABSSSI); community acquired bacterial pneumonia (CABP), and urinary tract infections (UTI), among other community-acquired bacterial infections. The company’s product candidate in phase 3, sarecycline is an oral, once-daily, antibiotic with anti-inflammatory properties for the treatment of acne and rosacea in the community setting. Paratek is headquartered in Boston, Massachusetts, the US.

Paratek Pharmaceuticals Inc Key Recent Developments

Nov 01,2017 Paratek Presents Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Oct 02,2017 Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)
Aug 02,2017 Paratek Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Clinical Update
Aug 01,2017 Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Argos Therapeutics Inc
  • Chimerix Inc
  • Titan Pharmaceuticals Inc
  • MORE
Section 1 - About the Company
  • Paratek Pharmaceuticals Inc - Key Facts
  • Paratek Pharmaceuticals Inc - Key Employees
  • Paratek Pharmaceuticals Inc - Key Employee Biographies
  • Paratek Pharmaceuticals Inc - Major Products and Services
  • Paratek Pharmaceuticals Inc - History
  • Paratek Pharmaceuticals Inc - Company Statement
  • Paratek Pharmaceuticals Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Paratek Pharmaceuticals Inc - Business Description
  • R&D Overview
  • Paratek Pharmaceuticals Inc - Corporate Strategy
  • Paratek Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Paratek Pharmaceuticals Inc - Strengths
  • Paratek Pharmaceuticals Inc - Weaknesses
  • Paratek Pharmaceuticals Inc - Opportunities
  • Paratek Pharmaceuticals Inc - Threats
  • Paratek Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Paratek Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Paratek Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Paratek Pharmaceuticals Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Nov 01, 2017: Paratek Presents Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
  • Oct 02, 2017: Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)
  • Aug 02, 2017: Paratek Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Clinical Update
  • Aug 01, 2017: Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
  • May 04, 2017: Paratek Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Clinical Update
  • Mar 24, 2017: Paratek Pharmaceuticals Opens New Office in King of Prussia
  • Mar 02, 2017: Paratek Pharmaceuticals Reports Full Year and Fourth Quarter 2016 Financial Results and Provides Clinical Update
  • Jan 04, 2017: Paratek Pharmaceuticals Announces Promotion of Evan Loh, M.D. to the role of President and Chief Operating Officer
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Paratek Pharmaceuticals Inc, Key Facts
  • Paratek Pharmaceuticals Inc, Key Employees
  • Paratek Pharmaceuticals Inc, Key Employee Biographies
  • Paratek Pharmaceuticals Inc, Major Products and Services
  • Paratek Pharmaceuticals Inc, History
  • Paratek Pharmaceuticals Inc, Other Locations
  • Paratek Pharmaceuticals Inc, Subsidiaries
  • Paratek Pharmaceuticals Inc, Key Competitors
  • Paratek Pharmaceuticals Inc, Ratios based on current share price
  • Paratek Pharmaceuticals Inc, Annual Ratios
  • Paratek Pharmaceuticals Inc, Annual Ratios
  • Paratek Pharmaceuticals Inc, Interim Ratios
  • Paratek Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Paratek Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Paratek Pharmaceuticals Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Paratek Pharmaceuticals Inc, Performance Chart (2012 - 2016)
  • Paratek Pharmaceuticals Inc, Ratio Charts
  • Paratek Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Paratek Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Titan Pharmaceuticals Inc
  • Chimerix Inc
  • Argos Therapeutics Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll